Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Explosive growth potential. That's the big draw for the stocks of small biotechs with COVID-19 development programs. One successful coronavirus vaccine or therapy could translate to a lot of revenue in a relatively short period of time.

Investors seeking this explosive growth have flocked to both Moderna (NASDAQ: MRNA) and Sorrento Therapeutics (NASDAQ: SRNE). Both biotech stocks have soared, thanks to key developments with their respective COVID-19 programs. But which of these coronavirus stocks is the better pick?

Here's how Moderna and Sorrento stack up against each other. 

Continue reading

Source Fool.com